219 related articles for article (PubMed ID: 30506129)
1. Promising practices for the prevention of liver cancer: a review of the literature and cancer plan activities in the National Comprehensive Cancer Control Program.
Momin B; Millman AJ; Nielsen DB; Revels M; Steele CB
Cancer Causes Control; 2018 Dec; 29(12):1265-1275. PubMed ID: 30506129
[TBL] [Abstract][Full Text] [Related]
2. An analysis of content in comprehensive cancer control plans that address chronic hepatitis B and C virus infections as major risk factors for liver cancer.
Momin B; Richardson L
J Community Health; 2012 Aug; 37(4):912-6. PubMed ID: 22160788
[TBL] [Abstract][Full Text] [Related]
3. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
4. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
Abruzzi A; Fried B; Alikhan SB
Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
[TBL] [Abstract][Full Text] [Related]
5. Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection.
Baffis V; Shrier I; Sherker AH; Szilagyi A
Ann Intern Med; 1999 Nov; 131(9):696-701. PubMed ID: 10577333
[TBL] [Abstract][Full Text] [Related]
6. Primary liver cancer deaths and related years of life lost attributable to hepatitis B and C viruses in India.
Islami F; Dikshit R; Mallath MK; Jemal A
Cancer Epidemiol; 2016 Feb; 40():79-86. PubMed ID: 26683034
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and prevention of hepatocellular carcinoma.
Franceschi S; Raza SA
Cancer Lett; 2009 Dec; 286(1):5-8. PubMed ID: 19070421
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hepatitis B virus infection and liver cancer.
Chang MH
Recent Results Cancer Res; 2014; 193():75-95. PubMed ID: 24008294
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E
World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937
[TBL] [Abstract][Full Text] [Related]
10. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
11. China's efforts to shed its title of "Leader in liver disease".
Li X; Xu WF
Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
[TBL] [Abstract][Full Text] [Related]
12. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
Lin CL; Kao JH
Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
[TBL] [Abstract][Full Text] [Related]
13. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of cancer survivorship activities across national comprehensive cancer control programs.
Underwood JM; Lakhani N; Rohan E; Moore A; Stewart SL
J Cancer Surviv; 2015 Sep; 9(3):554-9. PubMed ID: 25732543
[TBL] [Abstract][Full Text] [Related]
15. [Hepatocellular carcinoma: a preventable cancer].
Viviani S; Jack A; Bah E; Montesano R
Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
[TBL] [Abstract][Full Text] [Related]
16. Prevention of hepatitis B and C virus infection for prevention of cirrhosis and hepatocellular carcinoma.
Sung JL
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S370-6. PubMed ID: 9407359
[TBL] [Abstract][Full Text] [Related]
17. Cancer Plan Index: a measure for assessing the quality of cancer plans.
Rochester P; Adams E; Porterfield DS; Holden D; McAleer K; Steele CB
J Public Health Manag Pract; 2011; 17(6):E12-7. PubMed ID: 21964373
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus vaccine for patients with hepatitis C virus infection.
Chlabicz S; Grzeszczuk A
Infection; 2000; 28(6):341-5. PubMed ID: 11139151
[TBL] [Abstract][Full Text] [Related]
20. Reducing Cancer Risk Through Primary Prevention Activities Among Children: A Demonstration Project.
Tai E; Chovnick G; Momin B; Townsend JS; Holman DM; Siegel D; House M
J Public Health Manag Pract; 2024 Mar-Apr 01; 30(2):E54-E64. PubMed ID: 38032233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
